CTOs on the Move

Myelin Health

www.myelinhealth.com

 
Myelin Health is a network of companies linked by their experience and capabilities in the healthcare space. For payer and provider organizations, we create connections that make the most powerful messages mean even more.   Myelin Health operates a strong and collaborative system of communication experts with capabilities in creative digital and traditional solutions, strategy and branding concepts, integrated marketing and advertising content, research, data and analytics, mobile engagement, design and more.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

davaoncology LP

davaoncology LP is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Neibauer Dental

Neibauer Dental is a Waldorf, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Take Care Health Employer Solutions

Take Care Health Employer Solutions is a Conshohocken, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Luna NanoWorks

Luna NanoWorks is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Danville, VA. To find more information about Luna NanoWorks, please visit www.lunananoworks.com

MolecularMD

MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.